KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Depreciation and Depletion: 2013-2021

Historic Depreciation and Depletion for Arbutus Biopharma (ABUS) over the last 8 years, with Dec 2021 value amounting to $474,000.

  • Arbutus Biopharma's Depreciation and Depletion fell 6.88% to $474,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.8 million, marking a year-over-year decrease of 10.00%. This contributed to the annual value of $1.4 million for FY2024, which is 0.28% down from last year.
  • Latest data reveals that Arbutus Biopharma reported Depreciation and Depletion of $474,000 as of Q4 2021, which was up 6.04% from $447,000 recorded in Q3 2021.
  • In the past 5 years, Arbutus Biopharma's Depreciation and Depletion registered a high of $620,000 during Q4 2017, and its lowest value of $334,000 during Q1 2017.
  • Its 3-year average for Depreciation and Depletion is $485,667, with a median of $500,500 in 2020.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first surged by 103.78% in 2017, then decreased by 18.71% in 2018.
  • Over the past 5 years, Arbutus Biopharma's Depreciation and Depletion (Quarterly) stood at $620,000 in 2017, then declined by 18.71% to $504,000 in 2018, then grew by 0.60% to $507,000 in 2019, then climbed by 0.39% to $509,000 in 2020, then dropped by 6.88% to $474,000 in 2021.
  • Its last three reported values are $474,000 in Q4 2021, $447,000 for Q3 2021, and $436,000 during Q2 2021.